CD8A and neoplasm: IL-12, for example, promotes the differentiation of naïve CD4+ cells into type 1 T helper cells (Th1) and enhances CD8+ cytotoxic T cells (CTLs) and natural killer (NK) cells in their anti-tumor responses [16].